Literature DB >> 21740678

Lung cancer mortality in Spain: estimating the future burden to the year 2028.

A Cayuela1, S Rodríguez-Dominguez, J L López-Campos, L Jara-Palomares, R Otero, E Vigil.   

Abstract

OBJECTIVE: To use lung cancer mortality rates from 1979 to 2008 in Andalusia, southern Spain (population >8,000,000), to provide an estimate of the future number of deaths for the period 2009-2028.
DESIGN: The numbers of lung cancer deaths from 1979 to 2008 were obtained from the Andalusian Institute for Statistics (AIS). Data were arranged in 5-year age groups using an age-period-cohort model. Age-standardised rates (ASR) per 100, 000 were calculated for males and females. Population projections for Andalusia 2009-2028 were downloaded from the AIS database.
RESULTS: In males, the ASR varied from 46.1 in 2004-2008 to 34.6 in 2024-2028, with a projected 33% decrease. In females, the ASR varied from 4.9 in 2004-2008 to 8.9 per 100,000 in 2024-2028, with a projected 45% increase. This reflects an annual change of -1.3% for males and of +2.7% for females for the period 2009-2028. The sex ratio is projected to drop from a male:female ratio of 11 (1979-1983) to 3.8 (2024-2028).
CONCLUSIONS: Our projections emphasise the significance of a continuously increasing trend in female lung cancer mortality, with a drop in the projected sex ratio.

Entities:  

Mesh:

Year:  2011        PMID: 21740678     DOI: 10.5588/ijtld.10.0577

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  2 in total

1.  The lung cancer epidemic in Spanish women: an analysis of mortality rates over a 37-year period.

Authors:  Jose Luis López-Campos; Miguel Ruiz-Ramos; Carmen Calero
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 2.  Thoracic surgery in Spain.

Authors:  Gonzalo Varela; Florentino Hernando-Trancho; Pedro M Rodríguez Suárez; Jose R Jarabo Sarceda; Laureano Molins; Leire Azcárate
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.